223 related articles for article (PubMed ID: 15049272)
21. [Useful examinations and therapies in immunologic diseases].
Martenet AC
Klin Monbl Augenheilkd; 1993 May; 202(5):474-8. PubMed ID: 8377420
[TBL] [Abstract][Full Text] [Related]
22. Circulating anti-galectin-1 antibodies are associated with the severity of ocular disease in autoimmune and infectious uveitis.
Romero MD; Muiño JC; Bianco GA; Ferrero M; Juarez CP; Luna JD; Rabinovich GA
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1550-6. PubMed ID: 16565391
[TBL] [Abstract][Full Text] [Related]
23. Ocular manifestations of blistering diseases.
Elchahal S; Kavosh ER; Chu DS
Immunol Allergy Clin North Am; 2008 Feb; 28(1):119-36, vii. PubMed ID: 18282549
[TBL] [Abstract][Full Text] [Related]
24. Use of intravenous immunoglobulin therapy in autoimmune blistering diseases.
Ahmed AR
Int Immunopharmacol; 2006 Apr; 6(4):557-78. PubMed ID: 16504919
[TBL] [Abstract][Full Text] [Related]
25. IgG4-related disease in the eye and ocular adnexa.
Derzko-Dzulynsky L
Curr Opin Ophthalmol; 2017 Nov; 28(6):617-622. PubMed ID: 28858963
[TBL] [Abstract][Full Text] [Related]
26. [Practical management of the most common autoimmune bullous diseases].
Suárez-Fernández R; España-Alonso A; Herrero-González JE; Mascaró-Galy JM
Actas Dermosifiliogr; 2008; 99(6):441-55. PubMed ID: 18558052
[TBL] [Abstract][Full Text] [Related]
27. Therapy insight: scleritis and its relationship to systemic autoimmune disease.
Smith JR; Mackensen F; Rosenbaum JT
Nat Clin Pract Rheumatol; 2007 Apr; 3(4):219-26. PubMed ID: 17396107
[TBL] [Abstract][Full Text] [Related]
28. The role of cytokines in the regulation of ocular autoimmune inflammation.
Vallochi AL; Commodaro AG; Schwartzman JP; Belfort R; Rizzo LV
Cytokine Growth Factor Rev; 2007; 18(1-2):135-41. PubMed ID: 17349814
[TBL] [Abstract][Full Text] [Related]
29. [Therapeutics for future treatment of uveitis].
Deschênes J
Bull Soc Belge Ophtalmol; 2000; 276():7-11. PubMed ID: 10925522
[TBL] [Abstract][Full Text] [Related]
30. Intravenous immunoglobulin in eye involvement.
Tellier Z
Clin Rev Allergy Immunol; 2005 Dec; 29(3):295-306. PubMed ID: 16391405
[TBL] [Abstract][Full Text] [Related]
31. New biologic drugs: anti-interleukin therapy.
Tappeiner C; Möller B; Hennig M; Heiligenhaus A
Dev Ophthalmol; 2012; 51():79-89. PubMed ID: 22517206
[TBL] [Abstract][Full Text] [Related]
32. Rituximab in refractory autoimmune bullous diseases.
Schmidt E; Hunzelmann N; Zillikens D; Bröcker EB; Goebeler M
Clin Exp Dermatol; 2006 Jul; 31(4):503-8. PubMed ID: 16716150
[TBL] [Abstract][Full Text] [Related]
33. Gevokizumab in the Treatment of Autoimmune Non-necrotizing Anterior Scleritis: Results of a Phase I/II Clinical Trial.
Knickelbein JE; Tucker WR; Bhatt N; Armbrust K; Valent D; Obiyor D; Nussenblatt RB; Sen HN
Am J Ophthalmol; 2016 Dec; 172():104-110. PubMed ID: 27663070
[TBL] [Abstract][Full Text] [Related]
34. Treating autoimmune diseases through restoration of antigen-specific immune tolerance.
Wolfraim LA
Arch Immunol Ther Exp (Warsz); 2006; 54(1):1-13. PubMed ID: 16642252
[TBL] [Abstract][Full Text] [Related]
35. Gingival disorders of immune origin.
Castellano Suárez JL
Med Oral; 2002; 7(4):271-83. PubMed ID: 12134128
[TBL] [Abstract][Full Text] [Related]
36. Emerging treatments for pemphigoid diseases.
Ludwig RJ; Kalies K; Köhl J; Zillikens D; Schmidt E
Trends Mol Med; 2013 Aug; 19(8):501-12. PubMed ID: 23831338
[TBL] [Abstract][Full Text] [Related]
37. A review of evidence guiding the use of corticosteroids in the treatment of intraocular inflammation.
Gaudio PA
Ocul Immunol Inflamm; 2004 Sep; 12(3):169-92. PubMed ID: 15385194
[TBL] [Abstract][Full Text] [Related]
38. Biologic therapies for inflammatory eye disease.
Lim L; Suhler EB; Smith JR
Clin Exp Ophthalmol; 2006; 34(4):365-74. PubMed ID: 16764659
[TBL] [Abstract][Full Text] [Related]
39. Topical cyclosporine A as a steroid-sparing agent in steroid-dependent idiopathic ocular myositis with scleritis: a case report and review of the literature.
Gumus K; Mirza GE; Cavanagh HD; Karakucuk S
Eye Contact Lens; 2009 Sep; 35(5):275-8. PubMed ID: 19687744
[TBL] [Abstract][Full Text] [Related]
40. Intravenous immunoglobulin: recent advances in the treatment of autoimmune bullous diseases.
Daniel BS; Murrell DF
G Ital Dermatol Venereol; 2012 Jun; 147(3):259-67. PubMed ID: 22648327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
